Cargando…
Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28
PURPOSE: Familial chylomicronemia syndrome (FCS) is a rare genetic disorder characterized by high triglyceride levels, significant disease burden, and negative impacts on health-related quality of life. This project aimed to create a PROMIS-based patient-reported outcome measure that represents vali...
Autores principales: | Kaiser, Karen, Fox, Rina S., Perschon, Chelsea, Vera-Llonch, Montserrat, Alonso, Jordi, Cubells, Laia, Cella, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618409/ https://www.ncbi.nlm.nih.gov/pubmed/36310187 http://dx.doi.org/10.1007/s11136-022-03266-0 |
Ejemplares similares
-
Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience
por: Williams, Kate, et al.
Publicado: (2023) -
Identifying Patients with Familial Chylomicronemia Syndrome Using FCS Score-Based Data Mining Methods
por: Németh, Ákos, et al.
Publicado: (2022) -
Development of a novel PRO instrument for use in familial chylomicronemia syndrome
por: Davidson, David, et al.
Publicado: (2021) -
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021) -
Sustainability of FCs
por: Losito, Roberto
Publicado: (2023)